Imuran

Kidney Transplant Rejection

Imuran is used to prevent the body from rejecting a transplanted kidney. When a person receives a new organ, the immune system may identify it as a foreign object and attack it. Imuran works by suppressing the immune system to help the body accept the new kidney. It is usually prescribed as part of a combination therapy alongside other medications, such as corticosteroids.

Rheumatoid Arthritis

This medication is also indicated for the treatment of severe, active rheumatoid arthritis in adults. It is typically reserved for patients who have not responded well to standard treatments, including rest, physical therapy, and other medications. For these patients, Imuran can help to:

• Decrease joint pain and inflammation.
• Reduce swelling in the joints.
• Improve overall physical mobility.

By suppressing the overactive immune response that causes joint damage, the medication helps manage the long-term symptoms of the disease.

Other Potential Uses

In some clinical situations, healthcare providers may use Imuran to treat other autoimmune conditions where the immune system attacks the body's own tissues. This may include certain types of inflammatory bowel disease or other chronic inflammatory disorders, depending on the patient's specific medical needs and history.

Immune System Suppression

Imuran is classified as an immunosuppressant. It works by decreasing the activity and strength of the body's immune system. This is necessary when the immune system reacts in a way that causes harm, such as attacking a transplanted organ or healthy body tissues.

Cellular Interference

The active ingredient in Imuran is converted by the body into a substance that acts as an antimetabolite. This substance interferes with the synthesis of DNA, RNA, and proteins within cells. Because cells need these components to grow and multiply, the medication effectively slows down the production of new cells.

Impact on White Blood Cells

Imuran specifically affects certain types of white blood cells, known as T-cells and B-cells, which are key components of the immune response. By limiting the proliferation of these cells, the medication helps to:

• Prevent Organ Rejection: It stops the immune system from recognizing a transplanted kidney as a foreign invader and attacking it.
• Manage Autoimmune Responses: In conditions like rheumatoid arthritis, it reduces the immune system's ability to attack the body's own joints and tissues, which helps decrease inflammation and pain.

Common Side Effects

Some people experience mild side effects while taking Imuran, particularly when first starting the medication. These may include:

• Nausea and vomiting
• Loss of appetite
• Stomach pain
• Skin rash
• Hair loss or thinning

Serious Side Effects

Imuran can lower the body's ability to fight infection and may cause serious blood or liver problems. Contact a healthcare provider immediately if you notice:

• Signs of infection: Fever, chills, sore throat, or body aches.
• Liver problems: Yellowing of the skin or eyes, dark urine, or pain in the upper stomach.
• Blood disorders: Unusual bruising, pale skin, or easy bleeding.
• Severe gastrointestinal issues: Persistent diarrhea or severe nausea.
• Potential signs of cancer: New lumps, swollen lymph nodes, night sweats, or unexplained weight loss.

Joint pain and muscle aches are also possible and should be discussed with a doctor.

Boxed Warning: Risk of Cancer

Imuran has been associated with an increased risk of developing malignancies, such as lymphoma and skin cancer. A rare and often fatal type of cancer called hepatosplenic T-cell lymphoma has occurred, primarily in young adults and adolescents with inflammatory bowel disease who were also using certain other medications.

Bone Marrow Suppression

This medication can cause severe bone marrow suppression, leading to low counts of white blood cells, red blood cells, and platelets. This increases the risk of serious infection, anemia, and easy bruising or bleeding. Regular blood tests are necessary to monitor blood cell counts.

Infection Risk

Because Imuran suppresses the immune system, the body may be less able to fight off infections. This includes an increased risk of viral, bacterial, fungal, and protozoal infections, which can be severe or fatal.

Liver Toxicity

Liver damage (hepatotoxicity) can occur during treatment. Healthcare providers typically monitor liver function through periodic blood tests.

Genetic Considerations

Individuals with an inherited deficiency of the enzymes TPMT or NUDT15 are at a significantly higher risk for severe, life-threatening bone marrow toxicity when taking this medication.

Pregnancy and Reproduction

Imuran can cause fetal harm when administered to pregnant individuals. Effective contraception is generally recommended during treatment.

Pregnancy

Imuran can cause harm to a developing fetus. Clinical reports have indicated that taking this medication during pregnancy may increase the risk of birth defects or other complications. Individuals who are pregnant or planning to become pregnant should discuss the potential risks and benefits with their doctor before starting or continuing treatment.

It is important to use effective birth control while taking Imuran to prevent pregnancy. If you become pregnant while using this medication, notify your healthcare provider immediately to discuss the next steps for your care.

Breastfeeding

Azathioprine, the active ingredient in Imuran, and its metabolites can pass into breast milk in small amounts. Because of the potential for serious side effects in a nursing infant, breastfeeding is generally not recommended while using this drug. Patients should consult with their healthcare team to weigh the risks of the medication against the benefits of breastfeeding and to determine the safest course of action for the infant.

Available Forms

Imuran is provided in the following forms:

• Oral Tablet: This form is taken by mouth.
• Intravenous Injection: This form is administered into a vein by a healthcare professional and is typically used when oral administration is not possible.

FDA Approval and Indications

Imuran is approved by the U.S. Food and Drug Administration (FDA) for the following uses:

• Prevention of kidney transplant rejection.
• Treatment of severe, active rheumatoid arthritis in adults who have not responded to standard therapies.

Boxed Warning

Imuran carries a Boxed Warning, the FDA's most serious warning, regarding the risk of malignancy. Long-term use of this medication can increase the risk of developing certain cancers, such as lymphoma and skin cancer. Healthcare providers are advised to monitor patients for any signs of new growths or unusual symptoms.

Regulatory Safety Requirements

The FDA requires that patients using Imuran undergo frequent blood monitoring. This is necessary to detect potential bone marrow suppression, which can lead to serious infections or bleeding, and to monitor for liver damage (hepatotoxicity).

Generic Availability

Imuran is available as a generic medication called azathioprine. Generic drugs are typically much less expensive than brand-name versions while containing the same active ingredients and providing the same therapeutic effects.

Insurance Coverage

Most health insurance plans, including Medicare and Medicaid, cover the generic form of Imuran. The actual out-of-pocket cost for the patient will vary based on the specific insurance plan, including deductibles, copayments, and the plan's drug formulary. Brand-name Imuran may require a higher copay or special authorization from an insurance provider.

Factors Influencing Price

Several factors can affect the final price of this medication:

• Dosage and Quantity: The strength of the tablets and the total number of pills in the prescription.
• Pharmacy Selection: Prices can vary between different retail pharmacies, online pharmacies, and mail-order services.
• Patient Assistance: Some patients may be eligible for assistance programs if they do not have insurance or have high out-of-pocket costs.